Oral Oncology
Volume 40, Issue 7 , Pages 688-696 , August 2004

Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study

  • Sabrina D Silva

      Affiliations

    • Department of Oral Diagnosis, School of Dentistry of Piracicaba, UNICAMP, Av. Limeira 901, CP52, Areão, Piracicaba 13414-018, Brazil
    • ,
  • Michelle Agostini

      Affiliations

    • Department of Oral Diagnosis, School of Dentistry of Piracicaba, UNICAMP, Av. Limeira 901, CP52, Areão, Piracicaba 13414-018, Brazil
    • ,
  • Inês N Nishimoto

      Affiliations

    • Department of Head and Neck Surgery and Otorhinolaryngology, A.C. Camargo Cancer Hospital, Rua Prof. Antonio Prudente 211, Liberdade, 01509-010 São Paulo, Brazil
    • ,
  • Ricardo D Coletta

      Affiliations

    • Department of Oral Diagnosis, School of Dentistry of Piracicaba, UNICAMP, Av. Limeira 901, CP52, Areão, Piracicaba 13414-018, Brazil
    • ,
  • Fábio A Alves

      Affiliations

    • Department of Oral Diagnosis, School of Dentistry of Piracicaba, UNICAMP, Av. Limeira 901, CP52, Areão, Piracicaba 13414-018, Brazil
    • ,
  • Márcio A Lopes

      Affiliations

    • Department of Oral Diagnosis, School of Dentistry of Piracicaba, UNICAMP, Av. Limeira 901, CP52, Areão, Piracicaba 13414-018, Brazil
    • ,
  • Luiz P Kowalski

      Affiliations

    • Department of Head and Neck Surgery and Otorhinolaryngology, A.C. Camargo Cancer Hospital, Rua Prof. Antonio Prudente 211, Liberdade, 01509-010 São Paulo, Brazil
    • ,
  • Edgard Graner

      Affiliations

    • Department of Oral Diagnosis, School of Dentistry of Piracicaba, UNICAMP, Av. Limeira 901, CP52, Areão, Piracicaba 13414-018, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55-19-3412-5318; fax: +55-19-3412-5218

Received 13 October 2003 ,Accepted 18 December 2003.

References 

  1. Jayakumar A, Tai MH, Huang WY, al-Feel W, Hsu M, Abu-Elheiga L, et al.  Human fatty acid synthase: properties and molecular cloning. Proc. Natl. Acad. Sci. 1995;92(19):8695–8699
  2. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 2000;16(3):202–208
  3. Baron A, Migita T, Tang D, Loda M. Fatty acid synthase: a metabolic oncogene in prostate cancer?. J. Cell Biochem. 2004;91(1):47–53
  4. Weiss L, Hoffmann GE, Schreiber R, Andres H, Fuchs E, Korber E, et al.  Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol. Chem. Hoppe Seyler. 1986;367(9):905–912
  5. Chirala SS, Chang H, Matzuk M, Abu-Elheiga L, Mao J, Mahon K, et al.  Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero. Proc. Natl. Acad. Sci. USA. 2003;100(11):6358–6363
  6. Alo PL, Visca P, Marci A, Mangoni A, Botti C, Di Tondo U. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer. 1996;77(3):474–482
  7. Krontiras H, Roye GD, Beenken SE, Myers RB, Mayo MS, Peters GE, et al.  Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue. Head Neck. 1999;21(4):325–329
  8. Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, Heimburger DC, et al.  The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum. Pathol. 2000;31(9):1068–1073
  9. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, et al.  Delineation of prognostic biomarkers in prostate cancer. Nature. 2001;412(6849):822–826
  10. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, et al.  Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 2001;61(16):5974–5978
  11. Swinnen JV, Roskams T, Joniau S, Van Poppel H, Oyen R, Baert L, et al.  Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int. J. Cancer. 2002;98(1):19–22
  12. Kusakabe T, Nashimoto A, Honma K, Suzuki T. Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology. 2002;40(1):71–79
  13. Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, et al.  Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol. Cancer Res. 2003;1(10):707–715
  14. Visca P, Sebastiani V, Pizer ES, Botti C, De Carli P, Filippi S, et al.  Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma. Anticancer Res. 2003;23(1A):335–339
  15. Innocenzi D, Alo PL, Balzani A, Sebastiani V, Silipo V, La Torre G, et al.  Fatty acid synthase expression in melanoma. J. Cutan. Pathol. USA. 2003;30(1):23–28
  16. Takahiro T, Shinichi K, Toshimitsu S. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas. Clin. Cancer Res. 2003;9(6):2204–2212
  17. Gansler TS, Hardman W, Hunt DA, Schaffel S, Hennigar RA. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum. Pathol. 1997;28(6):686–692
  18. Alo PL, Visca P, Framarino ML, Botti C, Monaco S, Sebastiani V, et al.  Immunohistochemical study of fatty acid synthase in ovarian neoplasms. Oncol. Rep. 2000;7(6):1383–1388
  19. Lemmon MA, Schlessinger J. Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem. Sci. 1994;19(11):459–463
  20. Xu W, Mimnaugh E, Rosser MF, Nicchitta C, Marcu M, Yarden Y, et al.  Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J. Histol. Chem. 2001;276(5):3702–3708
  21. O-charoenrat P, Rhys-Evans PH, Modjtahedi H, Eccles SA. The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma. Oral Oncol. 2002;38(7):627–640
  22. Bargmann CI, Hung MC, Weinberg RA. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature. 1986;319(6050):226–230
  23. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 1997;16(7):1647–1655
  24. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235(4785):177–182
  25. Holbro T, Civenni G, Hynes NE. The ErB receptors and their role in cancer progression. Exp. Cell. Res. 2003;284(1):99–110
  26. Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, et al.  Her-2-neu expression and progression toward androgen independence in human prostate cancer. J. Natl. Cancer Inst. 2000;92(23):1918–1925
  27. Xia W, Lau YK, Zhang HZ, Liu AR, Li L, Kiyokawa N, et al.  Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin. Cancer Res. 1997;3(1):3–9
  28. Xia W, Lau YK, Zhang HZ, Xiao FY, Johnston DA, Liu AR, et al.  Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin. Cancer Res. 1999;5(12):4164–4174
  29. Werkmeister R, Brandt B, Joos U. Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas. Oral Oncol. 2000;36(1):100–105
  30. Bei R, Pompa G, Vitolo D, Moriconi E, Ciocci L, Quaranta M, et al.  Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma. J. Pathol. 2001;195(3):343–348
  31. Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D, et al.  Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. Clin. Cancer Res. 2002;8(2):540–548
  32. Khademi B, Shirazi FM, Vasei M, Doroudchi M, Gandomi B, Modjtahedi H, et al.  The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors. Cancer Lett. 2002;184(2):223–230
  33. Nagler RM, Kerner H, Laufer D, Ben-Eliezer S, Minkov I, Ben-Itzhak O. Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study. Cancer Lett. 2002;186(2):137–150
  34. Di Leo A, Dowsett M, Horten B, Penault-Llorca F. Current status of HER2 testing. Oncology. 2002;63(Suppl. 1):25–32
  35. Bartlett J, Mallon E, Cooke T. The clinical evaluation of HER-2 status: which test to use. J. Pathol. 2003;199(4):411–417
  36. Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res. 2003;63(1):132–139
  37. Furuya Y, Akimoto S, Yasuda K, Ito H. Apoptosis in androgen-independent prostate cell line induced by inhibition of fatty acid synthesis. Anticancer Res. 1997;17(6D):4589–4593
  38. Pizer ES, Chrest FJ, DiGiuseppe JA, Han WF. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res. 1998;58(20):4611–4615
  39. Li JN, Gorospe M, Chrest FJ, Kumaravel TS, Evans MK, Han WF, et al.  Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res. 2001;61(4):1493–1499
  40. Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand. J. Dent. Res. 1987;95(3):229–249
  41. Araujo CS, Graner E, Almeida OP, Sauk JJ, Coletta RD. Histomorphometric characteristics and expression of epidermal growth factor and its receptor by epithelial cells of normal gingiva and hereditary gingival fibromatosis. J. Periodontal. Res. 2003;38(3):237–241
  42. Swinnen JV, Van Veldhoven PP, Timmermans L, De Schrijver E, Brusselmans K, Vanderhoydonc F, et al.  Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains. Biochem. Biophys. Res. Commun. 2003;302(4):898–903
  43. Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res. 1997;57(6):1086–1090
  44. Swinnen JV, Heemers H, Deboel L, Foufelle F, Heyns W, Verhoeven G. Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene. 2000;19(45):5173–5181
  45. Lacasa D, Le Liepvre X, Ferre P, Dugail I. Progesterone stimulates adipocyte determination and differentiation 1/sterol regulatory element-binding protein 1c gene expression: potential mechanism for the lipogenic effect of progesterone in adipose tissue. J. Biol. Chem. 2001;276(15):11512–11516
  46. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell Physiol. 2000;182(3):311–322
  47. Bozlu M, Orhan D, Baltaci S, Yaman O, Elhan AH, Tulunay O, et al.  The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder. Int. Urol. Nephrol. 2002;33(1):59–66
  48. Wozniak A, Golusinski W, Kaczmarek E, Kaczmarek J, Kaczmarek J. Prognostic significance of Ki67 and PCNA expression in laryngeal squamous cell carcinoma (morphometric evaluation of labelling index-L1. Otolaryngol Pol. 2002;4(56):437–443
  49. Liu M, Lawson G, Delos M, Jamart J, Ide C, Coche E, et al.  Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations. Head Neck. 2003;25(4):280–288

PII: S1368-8375(04)00007-7

doi: 10.1016/j.oraloncology.2004.01.004

Oral Oncology
Volume 40, Issue 7 , Pages 688-696 , August 2004

Article Tools

* Image Usage & Resolution